AICARDI GOUTIERES SYNDROME
Clinical trials for AICARDI GOUTIERES SYNDROME explained in plain language.
Never miss a new study
Get alerted when new AICARDI GOUTIERES SYNDROME trials appear
Sign up with your email to follow new studies for AICARDI GOUTIERES SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for a devastating childhood disease: drug trial aims to halt progression
Disease control CompletedThis study tested a drug called baricitinib for children with Aicardi Goutières Syndrome (AGS), a rare and severe genetic disorder that causes brain damage and affects many organs. The goal was to see if the drug, taken for a year, could safely reduce harmful inflammation and hel…
Matched conditions: AICARDI GOUTIERES SYNDROME
Phase: PHASE2 • Sponsor: Adeline Vanderver, MD • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Gene test cuts diagnosis time for devastating childhood brain diseases from years to months
Diagnosis CompletedThis study tested whether using whole genome sequencing (a complete genetic map) as a first test could diagnose children with rare, inherited brain disorders called leukodystrophies faster and more accurately than the standard step-by-step approach. Researchers enrolled 236 child…
Matched conditions: AICARDI GOUTIERES SYNDROME
Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC